SEC Filing Summary: Global Medical REIT Inc. (GMRE)
Business Context and Reporting Period
This Form 8-K Current Report, dated September 18, 2025, pertains to Global Medical REIT Inc. (GMRE), a Maryland corporation. The filing details the implementation of a previously announced one-for-five reverse stock split of the Company's common stock. The effective time for the amendment was 5:00 p.m. Eastern Time on September 19, 2025.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance and capital structure adjustments related to the reverse stock split.
Material Changes
- Reverse Stock Split: Every five shares of issued and outstanding Common Stock were converted into one share.
- Authorized Shares: The authorized Common Stock was reduced proportionately from 500,000,000 shares to 100,000,000 shares.
- Par Value Adjustment: The par value was temporarily adjusted to $0.005 per share during the split and reverted to $0.001 per share immediately after the effective time.
- Trading Details: Common Stock resumed trading on the NYSE under the symbol "GMRE" on September 22, 2025, with a new CUSIP number (37954A 303).
- Fractional Shares: Fractional shares resulting from the split were settled via cash payment based on the closing price on September 19, 2025.
- Preferred Stock: The authorized preferred stock (10,000,000 shares) and its par value remained unchanged.
Guidance, Outlook, and Management Commentary
The filing does not contain forward-looking guidance, financial outlook, or management commentary regarding future performance. The primary communication is the confirmation of the reverse stock split's effectiveness and the administrative adjustments to equity plans.
Risks and Contingencies
The filing notes that the reverse stock split did not affect any record holder's percentage ownership interest, except for de minimis changes due to the elimination of fractional shares. No specific new risks or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the new CUSIP number (37954A 303) for the Common Stock.
- Confirm the adjusted share count in brokerage accounts following the one-for-five split.
- Check for cash payments received in lieu of fractional shares, expected within twenty days of the effective time.
- Review the adjusted terms of any outstanding equity awards under the 2016 Equity Incentive Plan.
- Confirm that trading resumed on September 22, 2025, under the symbol "GMRE."